These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2775468)

  • 41. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.
    Cohen ML; Fuller RW
    Life Sci; 1983 Feb; 32(7):711-8. PubMed ID: 6827905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apparent antinociceptive properties of piperazine-type serotonin agonists: trifluoromethylphenylpiperazine, chlorophenylpiperazine, and MK-212.
    McKearney JW
    Pharmacol Biochem Behav; 1989 Mar; 32(3):657-60. PubMed ID: 2740421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
    Chaouloff F; Aguerre S; Mormede P
    Neuropharmacology; 1998 Sep; 37(9):1159-67. PubMed ID: 9833646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.
    Antonatos S; Galanopoulou P
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):112-9. PubMed ID: 16242827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain.
    Piñeyro G; de Montigny C; Weiss M; Blier P
    Synapse; 1996 Jan; 22(1):54-62. PubMed ID: 8822478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Aulakh CS; Hill JL; Yoney HT; Murphy DL
    Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.
    Brown AM; Patch TL; Kaumann AJ
    Br J Pharmacol; 1991 Sep; 104(1):45-8. PubMed ID: 1786517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the effects of the 5-HT1 agonists TFMPP and RU 24969 on feeding following peripheral or medial hypothalamic injection.
    Fletcher PJ; Ming ZH; Zack MH; Coscina DV
    Brain Res; 1992 May; 580(1-2):265-72. PubMed ID: 1387034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.
    Benloucif S; Galloway MP
    Eur J Pharmacol; 1991 Jul; 200(1):1-8. PubMed ID: 1769366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats.
    Chojnacka-Wójcik E; Przegaliński E
    Neuropharmacology; 1991 Jul; 30(7):703-9. PubMed ID: 1681448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo.
    Prisco S; Pagannone S; Esposito E
    J Pharmacol Exp Ther; 1994 Oct; 271(1):83-90. PubMed ID: 7965760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
    Njung'e K; Handley SL
    Br J Pharmacol; 1991 Sep; 104(1):105-12. PubMed ID: 1686200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.
    Mueller EA; Murphy DL; Sunderland T
    Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The serotonin agonist, M-chlorophenylpiperazine, markedly increases levels of plasma catecholamines in the conscious rat.
    Bagdy G; Szemeredi K; Hill JL; Murphy DL
    Neuropharmacology; 1988 Oct; 27(10):975-80. PubMed ID: 3237317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-Hydroxytryptamine stimulates two distinct adenylate cyclase activities in rat brain: high-affinity activation is related to a 5-HT1 subtype different from 5-HT1A, 5-HT1B, and 5-HT1C.
    Fayolle C; Fillion MP; Barone P; Oudar P; Rousselle JC; Fillion G
    Fundam Clin Pharmacol; 1988; 2(3):195-214. PubMed ID: 3402898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.